BPC 157, TB 500, and GHK Cu: Separating Fact from Fear in Cancer Concerns Gabriel Alizaidy, MD, MS posted on the topic LinkedIn BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Bpc 157 Injection Method Subcutaneous Or Intramuscular LVLUP Health In Phoenix & Scottsdale, AZ Elite Plastic Surgery Where to inject BPC 157 for an orthopedic injury